Institucional y Patrimonio
Secondary containment for serious infectious disease research — designed for the failure consequences of the agent, not for a generic standard.
The market in detail
Biological containment facilities are among the most technically complex controlled environments in any sector. BSL-2 and BSL-3 laboratories require primary containment equipment, secondary containment architecture, airflow management and decontamination infrastructure to be integrated and validated as a single system. We design containment laboratories where every specification derives from the failure-mode consequences of the contained agent.
BSL-3 scope: dedicated HVAC with HEPA filtration on exhaust, effluent decontamination where the agent requires it, physical security measures appropriate to the risk group. WHO Laboratory Biosafety Manual, 4th ed. (2020), Directive 2000/54/EC, ISO 35001:2019+A1:2024. Commissioning documentation that supports inspection by the competent authority (AEMPS, COFEPRIS, ANMAT) and institutional biosafety committee review.
GMP-certified autonomous capacity in 4 to 6 months, deployed without interrupting existing production.
See more →Entornos controlados aplicables
Animal facilities under Directive 2010/63/EU and FELASA guidelines, with integrated biosafety.
See more →Entornos controlados aplicables
GMP-certified autonomous capacity in 4 to 6 months, deployed without interrupting existing production.
See more →Entornos controlados aplicables
Animal facilities under Directive 2010/63/EU and FELASA guidelines, with integrated biosafety.
See more →Entornos controlados aplicables
GMP-certified autonomous capacity in 4 to 6 months, deployed without interrupting existing production.
See more →Entornos controlados aplicables
Animal facilities under Directive 2010/63/EU and FELASA guidelines, with integrated biosafety.
See more →Entornos controlados aplicables
